Correlation Between SAB Biotherapeutics and Rezolute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Rezolute, you can compare the effects of market volatilities on SAB Biotherapeutics and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Rezolute.

Diversification Opportunities for SAB Biotherapeutics and Rezolute

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between SAB and Rezolute is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Rezolute go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Rezolute

Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 2.51 times more return on investment than Rezolute. However, SAB Biotherapeutics is 2.51 times more volatile than Rezolute. It trades about 0.06 of its potential returns per unit of risk. Rezolute is currently generating about -0.18 per unit of risk. If you would invest  292.00  in SAB Biotherapeutics on August 28, 2024 and sell it today you would earn a total of  11.00  from holding SAB Biotherapeutics or generate 3.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

SAB Biotherapeutics  vs.  Rezolute

 Performance 
       Timeline  
SAB Biotherapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Rezolute 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating essential indicators, Rezolute may actually be approaching a critical reversion point that can send shares even higher in December 2024.

SAB Biotherapeutics and Rezolute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SAB Biotherapeutics and Rezolute

The main advantage of trading using opposite SAB Biotherapeutics and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.
The idea behind SAB Biotherapeutics and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites